Laura Rienzi

Embryo development of fresh 'versus' vitrified metaphase II oocytes after ICSI: a prospective randomized sibling-oocyte study.

Predictive value of oocyte morphology in human IVF: a systematic review of the literature.

New culture devices in ART.

Consistent and predictable delivery rates after oocyte vitrification: an observational longitudinal cohort multicentric study.

The oocyte.

No evidence of association between blastocyst aneuploidy and morphokinetic assessment in a selected population of poor-prognosis patients: a longitudinal cohort study.

Oocyte versus embryo cryopreservation for fertility preservation in cancer patients: guaranteeing a women's autonomy.

Failure mode and effects analysis of witnessing protocols for ensuring traceability during IVF.

Electronic witness system in IVF-patients perspective.

Pre-implantation genetic testing in ART: who will benefit and what is the evidence?

PGS for recurrent pregnancy loss: still an open question.

Chapter 10 Human Oocyte Vitrification.

What is new in the management of poor ovarian response in IVF?

Prevalence of XXY karyotypes in human blastocysts: multicentre data from 7549 trophectoderm biopsies obtained during preimplantation genetic testing cycles in IVF.

Luteal phase anovulatory follicles result in the production of competent oocytes: intra-patient paired case-control study comparing follicular versus luteal phase stimulations in the same ovarian cycle.

Double Stimulation in the Same Ovarian Cycle (DuoStim) to Maximize the Number of Oocytes Retrieved From Poor Prognosis Patients: A Multicenter Experience and SWOT Analysis.

Impact of Maternal Age on Oocyte and Embryo Competence.

Inconclusive chromosomal assessment after blastocyst biopsy: prevalence, causative factors and outcomes after re-biopsy and re-vitrification. A multicenter experience.

Associations of blastocyst features, trophectoderm biopsy and other laboratory practice with post-warming behavior and implantation.

An integrated investigation of oocyte developmental competence: expression of key genes in human cumulus cells, morphokinetics of early divisions, blastulation, and euploidy.

Advanced Maternal Age in IVF: Still a Challenge? The Present and the Future of Its Treatment.

The main will of the patients of a private Italian IVF clinic for their aneuploid/affected blastocysts would be donation to research: a currently forbidden choice.

Looking past the appearance: a comprehensive description of the clinical contribution of poor-quality blastocysts to increase live birth rates during cycles with aneuploidy testing.

Time of morulation and trophectoderm quality are predictors of a live birth after euploid blastocyst transfer: a multicenter study.

Which key performance indicators are most effective in evaluating and managing an in vitro fertilization laboratory?

Assessment and management of the risk of SARS-CoV-2 infection in an IVF laboratory.

When embryology meets genetics: the definition of developmentally incompetent preimplantation embryos (DIPE)-the consensus of two Italian scientific societies.

The Impact of Unbalanced Maternal Nutritional Intakes on Oocyte Mitochondrial Activity: Implications for Reproductive Function.

Leave the past behind: women's reproductive history shows no association with blastocysts' euploidy and limited association with live birth rates after euploid embryo transfers.

Reply: 'Second stimulation in the same ovarian cycle', probably a terminology more appropriate than 'luteal phase stimulation' in the DuoStim protocol.

Is it in our patients' blood? On a quest for predictors of blastocysts' aneuploidy rate.

Oocyte competence is independent of the ovulation trigger adopted: a large observational study in a setting that entails vitrified-warmed single euploid blastocyst transfer.

Is a randomized controlled design sufficient for a trial to be valuable?

In vitro fertilization and andrology laboratories in 2030.

In vitro fertilization and andrology laboratory in 2030: expert visions.

Severe male factor in fertilization: definition, prevalence, and treatment. An update.

Maternal body mass index associates with blastocyst euploidy and live birth rates: the tip of an iceberg?

Measuring success in IVF is a complex multidisciplinary task: time for a consensus?